SCHEMBL7388336

SCHEMBL7388336

O=C(O)[C@H]1C[C@H](c2ccccc2)C1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.74
AKR1C1 Q04828 1/20 0.74
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
GRIN2B Q13224 3/20 0.45
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.44
HPGD P15428 1/20 0.44
GAA P10253 1/20 0.43
MAOB P27338 8/20 0.43
MAOA P21397 7/20 0.43
KDM1A O60341 5/20 0.43
CYP2C19 P33261 4/20 0.43
CYP2B6 P20813 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C9 P11712 2/20 0.43
LMNA P02545 2/20 0.43
TAAR1 Q96RJ0 2/20 0.43
CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11665023 1.00 AKR1C3 (0.74) AKR1C3AKR1C1NPC1RAB9AGRIN2B
SCHEMBL717453 1.00 AKR1C3 (0.74) AKR1C3AKR1C1NPC1RAB9AGRIN2B
SCHEMBL28629508 0.92 AKR1C3 (0.65) AKR1C3AKR1C1NPC1RAB9AGRIN2B
SCHEMBL17811172 0.85 AKR1C3 (1.00) AKR1C3AKR1C1NPC1RAB9AMAPT
SCHEMBL1073107 0.85 AKR1C3 (1.00) AKR1C3AKR1C1NPC1RAB9AMAPT
SCHEMBL26144401 0.85 AKR1C3 (1.00) AKR1C3AKR1C1NPC1RAB9AMAPT
SCHEMBL24923715 0.84 AKR1C3 (0.60) AKR1C3AKR1C1NPC1RAB9AGRIN2B
Bicarbonate SCHEMBL7576375 0.83 AKR1C3 (0.57) AKR1C3AKR1C1NPC1RAB9AGRIN2B
SCHEMBL16700099 0.83 AKR1C3 (0.53) AKR1C3AKR1C1NPC1RAB9AGRIN2B
SCHEMBL7945471 0.83 AKR1C3 (0.58) AKR1C3AKR1C1NPC1RAB9AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6054448-A TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM. ELI LILLY AND COMPANY LIMITED (GB) 2000-04-25 US disclosed
EP-0837061-A1 Pharmaceutical acidic compounds ELI LILLY AND COMPANY LIMITED (GB) 1998-04-22 EP disclosed